Investor Type | Firm |
Type of Fund | Private Equity Fund |
Industries | Software (Web Marketplace Saas..) • IT (& TMT) • Hardware (& Manufacturing) |
Stages | MBO/LBO, Recapitalization, Restructuring |
Investing | United States • China • Israel |
Assets Under Management | $1,000,000,000 |
Opus Point Partners, operating under the name Juggernaut Capital Partners, is a middle-market private equity fund based in Washington, District of Columbia. They specialize in investments across the consumer and healthcare markets with a particular focus on equity investments, including Management Buyouts (MBO), Leveraged Buyouts (LBO), Recapitalization, and Restructuring. With assets under management amounting to $1 billion, Juggernaut Capital Partners aims to foster growth and value creation within their portfolio companies. They invest in software sectors encompassing Web Marketplace and SaaS, IT and TMT, as well as Hardware and Manufacturing industries. Their investment thesis is centered around offering support, partnership, and value creation and they boast a strong specialization in private equity endeavors. Juggernaut is connected to over $115 billion in annual spend, providing distinctive data and insights. Such a comprehensive network places them at the convergence of their complementary portfolio, informing their decisions and strategies within the consumer, healthcare, and business services markets. The firm prides itself on benefiting founders and shareholders through collaborative plans aimed at value creation. Their consumer investments cover a range of sectors such as Health and Wellness, Personal Care, Beauty, Food, Beverage, Home, Active Living, Fitness, and Pet care. In the business services realm, they provide services to consumer products companies predominantly in Outsourcing, Sales & Marketing, Omnichannel Strategy, Retail Support, Sales Enablement, Product Innovation, and Testing. Moreover, their healthcare investments encompass pharmaceuticals and businesses that offer outsourced services to the healthcare industry, improving medical outcomes and consumer engagement.